U.S. Personal Products Stock News

Bitmine Immersion Technologies recently reported first-quarter 2025 results showing revenue of US$2.29 million and a very large net loss of US$5,204.10 million, while also appointing Young Kim as CFO, COO and board member effective January 1, 2026. At the same time, the company has amassed over 4.16 million ETH, about 3.45% of total supply, and is seeking approval to expand authorized shares to support further Ethereum accumulation and the planned MAVAN staking platform. We’ll now examine...

Trending interest in Sirius XM Holdings (SIRI) has picked up as investors weigh slower subscriber and revenue momentum against management’s expectation of higher free cash flow, which could support dividends and share repurchases. See our latest analysis for Sirius XM Holdings. The recent headlines around slower subscriber and revenue momentum, alongside management’s focus on higher free cash flow, come as the shares trade at US$20.81, with a 1-year total shareholder return of 2.47% but a...

S&P Global (SPGI) is back on investor radars after recent share price moves, with the stock up 8.2% over the past month and 12.3% in the past 3 months. See our latest analysis for S&P Global. Zooming out, S&P Global’s recent 1 month share price return of 8.2% and 3 month share price return of 12.3% sit alongside a 1 year total shareholder return of 12.7%. This suggests that momentum has recently picked up from a more moderate year to date gain. If S&P Global’s move has caught your attention,...

If you are wondering whether Urban Outfitters shares still offer value after a strong multi year run, this article walks through what the current price might be implying. The stock recently closed at US$73.16, with returns of a 9.4% decline over 7 days and a 10.6% decline over 30 days, set against a 30.9% return over 1 year and 168.1% over 5 years. Recent attention on Urban Outfitters has focused on how its current share price lines up with its fundamentals, as investors reassess what they...

If you are wondering whether Twilio's current share price really lines up with its fundamentals, this article is going to focus squarely on what you are getting for the price you pay. Twilio's share price recently closed at US$129.83, with returns of 19.4% over 1 year, a 134.9% return over 3 years and a 66.0% decline over 5 years. This suggests the market has shifted its view of the stock more than once. Recent attention on Twilio has centered on its position as a communications platform...

JPMorgan Chase (JPM) has capped FY 2025 with fourth quarter revenue of US$41.1b and basic EPS of US$4.64, alongside net income of US$12.7b, setting a clear marker for how the bank is exiting the year. The company has seen revenue move from US$40.1b in Q4 2024 to US$41.1b in Q4 2025, while quarterly EPS went from US$4.82 to US$4.64 over the same period, giving you a clean year on year reference point for the top and bottom line. With trailing net profit margins sitting just below last year and...

With no single headline event driving IonQ (IONQ) today, the focus for investors is on how its recent share performance and underlying business metrics line up against growing interest in quantum computing exposure. See our latest analysis for IonQ. The recent 1 day share price return of 3.94% decline extends a 90 day share price return of 32.41% decline, even as the 1 year total shareholder return sits at 65.84% and the 3 year total shareholder return is above 10x. This suggests earlier...

If you are wondering whether Lionsgate Studios is offering good value at its current price, you are not alone. Many investors are asking what a fair price really looks like for this stock. The share price last closed at US$9.05, with returns of 5.4% over 7 days, 10.5% over 30 days, a 2.7% decline year to date, and 37.6% over 1 year. The 3 year return sits at 53.8% and the 5 year return at a 16.6% decline. Recent headlines around Lionsgate Studios have focused on corporate actions, content...

If you are wondering whether Veeva Systems at around US$228.49 still offers good value, you are not alone; many investors are asking the same question. The stock shows mixed recent returns, with a 3.9% decline over the last 7 days, a 2.3% gain over 30 days, a 4.1% gain year to date, an 8.4% gain over 1 year, a 39.6% gain over 3 years, and a 17.8% decline over 5 years. Recent coverage has focused on Veeva Systems as a healthcare software company and how its share price history compares with...

If you are wondering whether Warner Bros. Discovery is still good value after its recent run, this article walks through what the current share price could be implying about the business. The stock closed at US$28.86, with returns of 0.9% over 7 days, a 2.9% decline over 30 days, 1.2% year to date, 194.8% over 1 year and 129.2% over 3 years, while the 5 year return sits at a 20.8% decline. Recent headlines around Warner Bros. Discovery have included ongoing attention on its combined...

In January 2026, Enovix Corporation reported independent third-party test results showing its AI-1 smartphone battery reached 935 Wh/L volumetric energy density, surpassing a leading commercially available silicon-doped smartphone battery tested under identical conditions. The tests highlight Enovix’s patented architecture using 100% active silicon anodes, which enables materially higher energy density than conventional graphite-based smartphone batteries. Next, we’ll examine how this...

Zscaler (ZS) has drawn fresh attention after appointing Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering, a role focused on securing autonomous AI agents that act as both users and applications. See our latest analysis for Zscaler. These leadership moves come after a year where Zscaler’s share price return has been mixed in the short term. Its 30 day share price return shows an 8.23% decline and its 90 day share price return shows a 28.28% decline, while...

In recent months, United Parcel Service has begun its largest-ever network reconfiguration, closing facilities such as its Cadillac site while rolling out agentic AI to handle over 90% of cross-border transactions and optimize dozens of locations across its logistics network. These changes have already been linked to improved efficiency and a double-digit increase in adjusted operating income, highlighting how automation and AI are reshaping UPS’s underlying business model. We’ll now examine...

Ionis Pharmaceuticals (IONS) is back in focus after highlighting 2025 progress and previewing a packed 2026 pipeline, including TRYNGOLZA sales of US$105 million, multiple potential product launches, and late stage clinical readouts. See our latest analysis for Ionis Pharmaceuticals. The latest pipeline update comes after a mixed few weeks for the stock, with a 1-day share price return of a 2.67% decline and a 7-day share price return of a 2.47% decline, while the 90-day share price return of...

If you are wondering whether Lumen Technologies at around US$8.15 is a bargain or a value trap, you are not alone. That is exactly what this article is here to unpack. The share price has seen a mix of shorter term softness, with a 1.8% decline over the last week and a 4.1% decline over the last month, alongside a 6.0% gain year to date and a 53.5% return over the past year, compared to a 45.8% return over three years and a 14.9% decline over five years. Recent coverage of Lumen has focused...

Amprius Technologies (AMPX) recently completed all sales under its at the market equity offering program, issuing 25.5 million shares and raising about US$97.5 million in net proceeds, a funding step many investors are watching closely. See our latest analysis for Amprius Technologies. The completion of the at the market program comes after a mixed run for the stock, with a 90 day share price return of a 33.81% decline but a 1 year total shareholder return of about 2 times. This suggests long...

With no single fresh headline driving attention, interest in Schrödinger (SDGR) today centers on its mix of software and drug discovery operations, its current share price of $18.31, and its recent return profile. See our latest analysis for Schrödinger. Recent trading has been choppy, with a 1 day share price return decline of 1.77% and a 90 day share price return decline of 11.16%, while the 1 year total shareholder return decline of 3.99% and 5 year total shareholder return decline of...

Hims & Hers Health (HIMS) is back in focus after Amazon Pharmacy said it will offer Novo Nordisk’s Wegovy weight loss pill, sharpening competition in a category Hims & Hers has been building into. See our latest analysis for Hims & Hers Health. The Amazon Pharmacy move comes after a choppy stretch for Hims & Hers, with a 30 day share price return decline of 13.46% and a 90 day share price return decline of 48.69%. However, the 1 year total shareholder return of 22.85% and the 3 year total...

McEwen (MUX) has just released final drill results from its newly acquired Tartan Mine Project near Flin Flon, Manitoba, an update closely tied to its long term plan to expand gold production capacity. See our latest analysis for McEwen. McEwen’s recent Tartan drill results and the closing of the Canadian Gold Corp. acquisition come after a 16.6% year to date share price return and a very large 1 year total shareholder return of 161.15%. This suggests momentum has been building as investors...

In recent months, multiple brokerages have updated their views on CenterPoint Energy, with BMO Capital upgrading the company to Outperform and a broad analyst consensus now also rating the stock as Outperform. This clustering of favorable opinions signals growing confidence in CenterPoint Energy’s business direction and regulatory positioning among professional analysts. Next, we’ll examine how this wave of Outperform ratings may influence CenterPoint Energy’s existing investment narrative...

Earlier this week, Salesforce rolled out a new AI-powered Slackbot as part of its Agentforce 360 vision, positioning Slack as a conversational interface that connects employees with organizational data, workflows, and third-party agents in real time while honoring existing permissions and access controls. This move highlights Salesforce’s attempt to make enterprise AI more usable day-to-day by embedding context-aware agents directly into familiar tools rather than adding separate, complex...

NWPX Infrastructure (NWPX) is attracting fresh attention after reporting the first commercial use of its patent pending Permalok Radial Bending Joint in Tampa Bay Water’s South Hillsborough Pipeline microtunneling project. See our latest analysis for NWPX Infrastructure. At a latest share price of $67.29, NWPX Infrastructure has paired the Permalok RBJ milestone with steady short term momentum, including a 7 day share price return of 5.12%. Longer term total shareholder returns of 41.99% over...

Royalty growth outlook and capital deployment signal focus areas for investors Ligand Pharmaceuticals (LGND) recently highlighted an expected 40% royalty revenue increase in 2026 and a 23% compound annual growth rate projection through 2030, alongside more than US$1b in deployable capital for new investments. See our latest analysis for Ligand Pharmaceuticals. Those royalty growth projections and the large capital pool are arriving after a sharp move in the stock, with a 1 year total...

Zevra Therapeutics (ZVRA) is in focus as its leadership prepares to present at the J.P. Morgan 44th Annual Healthcare Conference on January 15, 2026, where it will outline rare disease programs and broader growth plans. See our latest analysis for Zevra Therapeutics. The upcoming J.P. Morgan conference appearance follows a 1-day share price return of 6.44% and a 7-day share price return of 7.34%. Over the past 90 days, the share price declined by 24.28%, contrasting with a 1-year total...